(Continued)
Abbreviations: CEA, carcinoembryonic antigen; CISH, chromogenic in situ hybridization; CNS, central nervous system; COX-2, cyclo-oxygenase 2; DCIS, ductal carcinoma in situ; DFS, disease-free survival; DMFS, distant metastasis-free survival; EGFR, epidermal growth factor receptor; ELISA, enzyme-linked immunosorbent assay; EpCAM, epithelial cell adhesion molecule; ER, estrogen receptor; FISH, fluorescence in situ hybridization; FOX, forkhead box; HER-2, human epidermal growth factor receptor 2; HR, hazard ratio; IA, image analysis; IDC, invasive ductal carcinoma; IHC, immunohistochemistry; ILC, invasive lobular carcinoma; MFS, metastasis-free survival; MIB1, mindbomb homolog 1; MMP13, matrix metalloproteinase 13; OS, overall survival; PCNA, proliferating cell nuclear antigen; PgR, progesterone receptor; RFS, relapse-free survival; RR, relative risk; RT-PCR, real-time polymerase chain reaction; SLP2, stomatin-like protein 2; TGF-α, transforming growth factor α; TNM, tumor–node–metastasis; TOP2A, topoisomerase IIα.
(Continued)
Abbreviations: CEA, carcinoembryonic antigen; CISH, chromogenic in situ hybridization; CNS, central nervous system; COX-2, cyclo-oxygenase 2; DCIS, ductal carcinoma in situ; DFS, disease-free survival; DMFS, distant metastasis-free survival; EGFR, epidermal growth factor receptor; ELISA, enzyme-linked immunosorbent assay; EpCAM, epithelial cell adhesion molecule; ER, estrogen receptor; FISH, fluorescence in situ hybridization; FOX, forkhead box; HER-2, human epidermal growth factor receptor 2; HR, hazard ratio; IA, image analysis; IDC, invasive ductal carcinoma; IHC, immunohistochemistry; ILC, invasive lobular carcinoma; MFS, metastasis-free survival; MIB1, mindbomb homolog 1; MMP13, matrix metalloproteinase 13; OS, overall survival; PCNA, proliferating cell nuclear antigen; PgR, progesterone receptor; RFS, relapse-free survival; RR, relative risk; RT-PCR, real-time polymerase chain reaction; SLP2, stomatin-like protein 2; TGF-α, transforming growth factor α; TNM, tumor–node–metastasis; TOP2A, topoisomerase IIα.
